Objective: To examine dose-response relationships between internal uranium exposures and select outcomes among a cohort of uranium enrichment workers. Results: Elevated and monotonically increasing mortality risks were observed for kidney cancer, chronic renal diseases, and multiple myeloma, and the association with internal uranium absorbed organ dose was statistically significant for multiple myeloma.
technetium (
99 Tc) in recycled uranium as potential confounders. This current study also includes evaluation of linear-quadratic and restricted cubic splines regression models in addition to the linear excess relative risk (ERR) model reported in the previous study. 1 The clarification of the relationship between kidney and red bone marrow dose from occupational exposure to uranium and health risk will aid in evaluating current levels of protection and ultimately reduce cancer mortality for workers in the uranium fuel cycle.
| MATERIALS AND METHODS

| Study cohort
The details on the cohort and case ascertainment were described previously. 1 Briefly, the study subjects included a pooled cohort of workers from three uranium enrichment facilities: K-25, PORTS, and PGDP. Eligible workers were limited to those who worked for at least 
| Internal uranium exposure
A detailed description of the methods is found in the papers by
Anderson et al 2 and Anderson and Apostoaei. 3 Briefly, uranium gravimetric and radioactivity concentration for >600 000 urine samples was abstracted from facility bioassay records. For workers with no reported bioassay data, urine uranium excretion was imputed using department-specific uranium concentrations averaged from reported bioassay data. Novel methods were used to estimate effective enrichment for workers by linking department numbers from work history records with calculated department-and facility-specific enrichments. Workers were then assigned an enrichment level for each record in their work history associated with a department number and then an effective enrichment was calculated for each worker. The effective enrichment was converted to specific activity which was used to convert gravimetric uranium data to radioactivity concentration.
Reported and imputed bioassay data were used to calculate intakes assuming a chronic exposure from the first date through the last date of employment. Annual absorbed organ doses to lungs, bone surface, red bone marrow, kidneys, and liver were calculated from the intakes and accumulated for each worker until the date of last observation (ie, date of death, date lost to follow-up, or the study end date of December 31, 2011). Absorbed organ doses to lungs and liver are not used in this report as they are not applicable to the health outcomes investigated. Tc or gross beta were abstracted from electronic databases, and historical plant records were examined to ascertain bioassay program procedures, analytical methods, and detection levels for the radionuclides of interest. Urinalysis data for contaminant radionuclides were available for <10% of the cohort, so bioassay data were imputed using the same methods as for uranium and are described in detail by Anderson et al. 4 Intakes were calculated assuming a chronic exposure from the first date through the last date of employment.
Absorbed dose to the bone surface, red bone marrow, and kidney were calculated as these were the target organs associated with a priori outcomes of interest. Several regression models were used to evaluate the relation between each outcome and corresponding internal uranium organ dose.
The primary models included: 1) linear, f(X) = 1 + βX where β is the estimated model parameter for the main exposure of interest X; and 2) linear-quadratic, f(X) = 1 + β 1 X + β 2 X 2 . Additionally, a categorical model was examined with three exposed groups, with cut points at the 33rd and 66th percentile of the exposed cases' exposure distribution, compared to the non-exposed reference group. The shape of the doseresponse was further examined by restricted cubic splines (RCS) with three knots at equally spaced points (ie, at the 95th percentile and at 1/3 and 2/3 of the 95th percentile) across the dose distribution. The Akaike Information Criterion (AIC) 16 was used to evaluate model fit. In addition,
for each outcome, a grid search was used to find the lag that maximized the likelihood function. 17 The hazard ratio (HR) at 50th and 75th
percentiles of dose compared with the non-exposed and corresponding 95% profile likelihood-based confidence intervals (CIs) were derived with restriction to workers with no more than the 95th percentile of dose. To account for choosing the best fitting lag for each model, 95%
CIs were calculated with 2 degrees of freedom.
18
TABLE 1 Demographics of gaseous diffusion plant workers with follow-up through 12/31/2011
Primary facility were not included in the present study as they were unlikely confounders due to poor correlations with internal uranium organ doses in the previous report. 1 All analyses were conducted using SAS software. 19 
| RESULTS
The study included 29 303 eligible workers who worked for at least 1 year continuously within the specified time periods at the three uranium enrichment facilities. There were 16 978, 6 935, and 5 390 workers with K-25, PORTS, and PGDP, respectively, as the primary facility. The cohort was mostly male (81%) and white (93%), and had an average age at hire of 29.2 years and employment duration of 13.9 years. Approximately 45% of the cohort was deceased at the end of follow-up (Table 1) .
Bioassay data on internal uranium were available for 58% of the cohort and were imputed for an additional 33%. The remaining 9% who had no reported or imputed bioassay data were assumed to be unexposed. K-25 had the highest number of workers with imputed uranium data (45% of the cohort). Only 13% of PORTS workers had imputed uranium data. Table 2 Tables 3 and 4 
| DISCUSSION
In the previous study, we pooled information from uranium worker cohorts and extended follow-up to examine mortality patterns in the TABLE 3 Hazard ratios and 95% confidence intervals of internal absorbed organ doses at 50th and 75th percentiles of dose vs. non-exposed, and with adjustment for external radiation without X-ray or contaminant radionuclide | 611 largest group of uranium enrichment workers assembled. Despite evidence of a strong "healthy worker effect" as found in a recent French uranium enrichment worker study, 20 there was weak evidence in the standardized mortality ratio (SMR) analysis suggesting excess mortality from kidney and bone cancers in these workers compared to the U.S.
population. Furthermore, internal comparison using the linear ERR model showed positive but not statistically significant dose-response relations between absorbed kidney dose from internally-deposited soluble uranium and kidney cancer and chronic non-malignant kidney diseases. 1 We also observed a statistically significant positive association between red bone marrow dose and multiple myeloma.
Major factors to cancer risk such as family history of cancer, socioeconomic status, and lifestyle factors (diet, smoking, and alcohol consumption), were still lacking in the study. However, we improved upon the previous study by adopting various regression models and including contaminant radionuclides in recycled uranium as potential confounders to clarify the dose-response relationships. The ionizing radiation exposure from both external sources and work-related X-rays is due to relatively low-energy gamma rays with a relative biological effectiveness (RBE) of unity, whereas the internal exposure was due mostly to the alphaemitting radioisotopes of uranium and plutonium and the beta emissions from 99
Tc. The analyses reported in this study indicate that there is no statistically significant confounding by external ionizing radiation exposure or internal exposure to the contaminant radionuclides.
Our best fit models for certain cancers had lags longer than the 10-20 years usually used in other studies. Daniels et al 17 reported that temporal risk patterns appeared to vary by cancer type, and the excess risk of certain cancers may span several decades. Our report of late onset of exposure-related mortality also suggested additional followup of these workers to fully describe their lifetime risks. The suggestion of a dose-response between internal uranium exposure and kidney cancer and non-malignant kidney disease is not unexpected given that the kidney is a target organ for soluble uranium. 21 However, previous studies of uranium-exposed cohorts have not indicated any excess risk for these health outcomes, possibly due to low statistical power or limited cases. Bone surface is also a target organ for soluble uranium. Neither the linear nor the linear-quadratic models gave point estimates for bone cancer mortality, but the categorical and spline models showed attenuated risk among the highest exposed. Nonlinear doseresponses with an increasing slope at lower exposures followed by attenuated risk at higher exposures are common to occupational studies. 22 While a healthy worker survivor effect could cause negative or attenuated dose-response, it seems less likely to explain our findings in NHL and leukemia, as relatively short latency periods in these diseases (best fitted lags of 7-9 years) tend to reduce a healthy worker survivor effect. Also, the effect of imputing doses is unknown and could not be evaluated in this study due to the low number of deaths from the outcomes of interest.
However, the effect of imputation on dose-response modeling will be investigated in a future study of cardiovascular disease mortality.
The finding of a statistically significant dose-response for bone marrow dose from internally-deposited uranium and multiple myeloma mortality is consistent with a previous case-control study of multiple myeloma mortality in the K-25 cohort. 8 Multiple myeloma is a cancer resulting in proliferation of abnormal plasma cells which crowd out normal bone marrow cells, such as red and white blood cells and platelets. Renal insufficiency has been associated with decreased overall survival among multiple myeloma patients, 23 so it is possible that uranium exposure of the kidneys results in increased mortality. A forthcoming cancer incidence study will be able to compare myeloma incidence to mortality in the cohort.
| CONCLUSION
Consistent with previous findings, we observed a statistically significantly positive association between red bone marrow dose and multiple myeloma mortality using different regression models in this pooled uranium worker cohort. Elevated and monotonically increasing mortality risks were also observed for kidney cancer and chronic renal diseases. Adjustment for potential confounders such as external radiation and contaminant radionuclides in recycled uranium did not alter the results in terms of direction and significance. These findings further improve our understanding of the relation between protracted exposures to uranium compounds and cancers and chronic renal diseases. Continued follow-up of these uranium cohorts may help to clarify dose-response relations and be useful in evaluating current levels of protection for workers in the uranium fuel cycle.
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